UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000048888
Receipt No. R000055688
Scientific Title Survey of treatment pattern and prognosis about diabetic macular edema in Japan
Date of disclosure of the study information 2022/09/20
Last modified on 2022/09/08 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Survey of treatment for diabetic macular edema in Japan
Acronym STREAT-DME 2 study
Scientific Title Survey of treatment pattern and prognosis about diabetic macular edema in Japan
Scientific Title:Acronym STREAT-DME 2 study
Region
Japan

Condition
Condition diabetic macular edema
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To conduct a nationwide survey on the treatment pattern and treatment prognosis for two years from the start of intervention for diabetic macular edema in Japan.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Dynamic change of visual improvement after 2-years from initial intervention
Key secondary outcomes Dynamic change of treatment pattern during 2 years of clinical course

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria treatment-naive diabetic macular edema who have medical record during 2 years since initial intervention
Key exclusion criteria patients who had vitreous retinal disease other than diabetic retinopathy
Target sample size 2000

Research contact person
Name of lead principal investigator
1st name Masahiko
Middle name
Last name SHIMURA
Organization Tokyo Medical University Hachioji Medical Center
Division name Department of Ophthalmology
Zip code 193-8639
Address 1163 Tate-machi, Hachioji, Tokyo
TEL +81426655611
Email masahiko@v101.vaio.ne.jp

Public contact
Name of contact person
1st name Masahiko
Middle name
Last name SHIMURA
Organization Tokyo Medical University Hachioji Medical Center
Division name Department of Ophthalmology
Zip code 193-8639
Address 1163 Tate-machi, Hachioji, Tokyo
TEL +81426655611
Homepage URL
Email kelloggmi@yahoo.co.jp

Sponsor
Institute Tokyo Medical University
Institute
Department

Funding Source
Organization Japan Society for the Promotion of Science
Organization
Division
Category of Funding Organization Non profit foundation
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Institutional Review Board in Tokyo Medical University
Address 6-7-1 Nishi-Shinjuku, Shinjuku, Tokyo
Tel 0333426111
Email tokyo-med@esct.bvits.com

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 09 Month 20 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2022 Year 05 Month 01 Day
Date of IRB
2022 Year 06 Month 01 Day
Anticipated trial start date
2022 Year 07 Month 01 Day
Last follow-up date
2022 Year 12 Month 31 Day
Date of closure to data entry
2022 Year 12 Month 31 Day
Date trial data considered complete
2023 Year 03 Month 31 Day
Date analysis concluded
2023 Year 12 Month 31 Day

Other
Other related information Treatment naive diabetic macular edema
Initial intervention received from 2015 to 2019
Each case had medical record more than 2years since initial intervention
Visual acuity and central macular thickness recorded at the time of intervention and final date of 2-years.

Management information
Registered date
2022 Year 09 Month 08 Day
Last modified on
2022 Year 09 Month 08 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055688